These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20230416)

  • 21. Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.
    Canonico M; Bouaziz E; Carcaillon L; Verstuyft C; Guiochon-Mantel A; Becquemont L; Scarabin PY;
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3082-7. PubMed ID: 18628519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
    Mohammed K; Abu Dabrh AM; Benkhadra K; Al Nofal A; Carranza Leon BG; Prokop LJ; Montori VM; Faubion SS; Murad MH
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4012-20. PubMed ID: 26544651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy use and the risk of stroke.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.
    Goldštajn MŠ; Mikuš M; Ferrari FA; Bosco M; Uccella S; Noventa M; Török P; Terzic S; Laganà AS; Garzon S
    Arch Gynecol Obstet; 2023 Jun; 307(6):1727-1745. PubMed ID: 35713694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.
    Ohira T; Folsom AR; Cushman M; White RH; Hannan PJ; Rosamond WD; Heckbert SR
    Br J Haematol; 2010 May; 149(4):606-12. PubMed ID: 20230397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Oedingen C; Scholz S; Razum O
    Thromb Res; 2018 May; 165():68-78. PubMed ID: 29573722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study.
    Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH
    Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral postmenopausal hormone therapy and genetic risk on venous thromboembolism: gene-hormone interaction results from a large prospective cohort study.
    Kim J; Bhupathiraju SN; Harrington LB; Hagan KA; Lindström S; Manson JE; Kraft P; Kabrhel C
    Menopause; 2022 Jan; 29(3):293-303. PubMed ID: 35013060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
    Scarabin PY; Oger E; Plu-Bureau G;
    Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans.
    Blondon M; Timmons AK; Baraff AJ; Floyd JS; Harrington LB; Korpak AM; Smith NL
    Menopause; 2021 Jul; 28(10):1125-1129. PubMed ID: 34313612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.